跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Timoptol - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Timoptol
Approved
STANDARD
Timoptol
Laboratories Merck Sharp & Dohme-Chibret
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
4eb03246099da115
Company
Laboratories Merck Sharp & Dohme-Chibret
Type
Standard
Approval Details
Approval Id
4eb03246099da115
Drug Approval Philippines Name
Timoptol
Product Name
Timoptol
Registration Number
DR-X6980
Brand Name
Timoptol
Generic Name
Timolol maleate
Dosage Form
Sterile Ophthalmic Solution
Dosage Strength
5 mg/ mL (0.5% w/v)
Manufacturer
Laboratories Merck Sharp & Dohme-Chibret
Importer
Santen Philippines Inc.
Issuance Date
25 May 2025
Expiry Date
02 August 2031
Pharmacologic Category
Anti-glaucoma (Beta Blocking Agent)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
4eb03246099da115
Type
Standard
Back to Philippines FDA Approvals